Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
Recent Share tips:
- Watch Tesco (TSCO) by Zaven Boyrazian in The Motley Fool
- Overweight Endeavour Mining (EDV) by Barclays
- Buy BP (BP.) by Manika Premsingh in The Motley Fool
- Buy Royal Dutch Shell 'B' (RDSB) by Manika Premsingh in The Motley Fool
- Long Term Buy Burberry Group (BRBY) by Manika Premsingh in The Motley Fool
- Avoid On The Beach Group (OTB) by Chris Bailey in ShareProphets
- Buy Sirius Real Estate Ltd. (SRE) by Berenberg
- Buy Unilever (ULVR) by Deutsche Bank
- Underperform Admiral Group (ADM) by Credit Suisse
- Speculative Buy Synairgen (SNG) by Rupert Hargreaves in The Motley Fool
- Buy BT Group (BT.A) by Nadia Yaqub in The Motley Fool
- Buy Admiral Group (ADM) by Jonathan Smith in The Motley Fool
- Buy Sainsbury (J) (SBRY) by Jonathan Smith in The Motley Fool
- Buy Serica Energy (SQZ) by Gary Newman in ShareProphets
- Avoid TP Group (TPG) by Steve Moore in ShareProphets
- Speculative Buy Brown (N.) Group (BWNG) by Roland Head in The Motley Fool
- Buy DFS Furniture (DFS) by Harshil Patel in The Motley Fool
- Buy Future (FUTR) by Harshil Patel in The Motley Fool
- Buy SCS Group (SCS) by Harshil Patel in The Motley Fool
- Underperform SSP Group (SSPG) by Credit Suisse
Hikma Pharmaceuticals (HIK)
Health Care Sector
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Jabran Khan | – | 2021-06-16 16:10:00 16/06/2021 | – |
| – | Harvey Jones | – | 2021-06-09 10:50:00 09/06/2021 | – |
| – | Citi | – | 2021-06-08 14:30:00 08/06/2021 | – |
| – | G A Chester | – | 2021-06-03 13:30:00 03/06/2021 | – |
| – | Rupert Hargreaves | – | 2021-05-08 07:40:00 08/05/2021 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Hikma Pharmaceuticals Overview
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma's operations are in the United States, the Middle East and North Africa Region and Europe.Latest Hikma Pharmaceuticals Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Jabran Khan | – | 2021-06-16 16:10:00 16/06/2021 | – |
| – | Harvey Jones | – | 2021-06-09 10:50:00 09/06/2021 | – |
| – | Citi | – | 2021-06-08 14:30:00 08/06/2021 | – |
| – | G A Chester | – | 2021-06-03 13:30:00 03/06/2021 | – |
| – | Rupert Hargreaves | – | 2021-05-08 07:40:00 08/05/2021 | – |